FOR PHARMACISTS · REFERENCE EDITION 8.0261 monographs · 32 SOPs · 18 forms

SOP-022 / SOP v1.0

Cleaning verification for actives and allergens

Shared equipment and surfaces at risk of residue carryover.

Procedure

  1. Select worst-cleaning substances and locations using toxicity, dose, solubility, adhesion and geometry.
  2. Set a scientifically/toxicologically justified residue limit for the next use. Do not adopt universal 10 ppm or zero without method and rationale.
  3. Verify swab or rinse recovery from actual surface materials, suitable LOQ and cleaning-agent interference.
  4. Perform the approved method and record exact cleaner, dilution, time, mechanical action and rinsing.
  5. Assess visual inspection together with required analytical results. ATP or disinfection does not establish removal of allergens or potent drugs.
  6. Release the area only after acceptance. Failure requires investigation, justified recleaning or dedicated equipment, with assessment of previous batches.
Stop criterion

Failed limit or unsuitable method: no subsequent shared use.

Related forms

F-015, F-004, F-007

Sources and references

  1. NIOSH — Managing Hazardous Drug Exposures: Information for Healthcare SettingsDHHS (NIOSH) 2023-130Risk assessment and activity-specific control table, printed pp. 27–33Exposure routes and hierarchy of occupational controls2026-09-12
  2. PIC/S — Guide to Good Practices for the Preparation of Medicinal Products in Healthcare EstablishmentsPE 010-4, 1 March 2014Chapters 1–9; Annex 2 (nonsterile liquids, creams, ointments)Professional quality-system framework; not automatic national legal adoption or certification2026-09-12
  3. EMA — Guideline on Allergen Products: Production and Quality IssuesEMEA/CHMP/BWP/304831/2007, 2008Sections 2, 4.1.1, 4.2.4, 4.3, 4.4.3–4.4.5; pp. 4–13Industrial biological-allergen quality guidance; principles adapted explicitly, not a compounding authorisation or a food-OIT recipe2026-09-12